ImpediMed Limited
IPDQF
$0.0445
$0.004812.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.67M | 7.27M | 6.82M | 6.89M | 7.00M |
| Total Other Revenue | -54.00K | -27.30K | -500.00 | 10.80K | 21.70K |
| Total Revenue | 7.61M | 7.22M | 6.77M | 6.85M | 6.97M |
| Cost of Revenue | 922.80K | 895.10K | 861.80K | 882.60K | 909.50K |
| Gross Profit | 6.69M | 6.32M | 5.91M | 5.96M | 6.06M |
| SG&A Expenses | 17.00M | 17.31M | 17.51M | 17.56M | 17.70M |
| Depreciation & Amortization | 2.18M | 1.84M | 1.48M | 1.56M | 1.64M |
| Other Operating Expenses | 2.43M | 2.35M | 2.26M | 2.08M | 1.93M |
| Total Operating Expenses | 22.59M | 22.45M | 22.18M | 22.15M | 22.25M |
| Operating Income | -14.97M | -15.23M | -15.41M | -15.30M | -15.28M |
| Income Before Tax | -13.98M | -13.51M | -12.96M | -12.88M | -12.89M |
| Income Tax Expenses | 15.90K | 18.80K | 21.60K | 20.00K | 18.40K |
| Earnings from Continuing Operations | -14.00 | -13.53 | -12.98 | -12.90 | -12.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.00M | -13.53M | -12.98M | -12.90M | -12.91M |
| EBIT | -14.97M | -15.23M | -15.41M | -15.30M | -15.28M |
| EBITDA | -13.23M | -13.83M | -14.36M | -14.26M | -14.24M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 4.05T | 4.05T | 4.04T | 4.04T | 4.04T |
| Average Diluted Shares Outstanding | 4.05T | 4.05T | 4.04T | 4.04T | 4.04T |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
